. 2022 Jun 14;13:881484. doi: 10.3389/fphys.2022.881484

TABLE 2.

Measures related to training during the 6-weeks prehabilitation period of both training groups.

	BFR (N = 10)	AC (N = 10)	One-way ANOVA/rANOVA (p/η_p ²)
			Time		Group		Time x group
			BFR	AC	Phase 1	Phase 2	Time x group
Exercise intensity (W)
Phase 1 (session 1–6)	62.5 (17.5)	69.0 (17.5)	<0.001/0.902	<0.001/0.900	0.417/0.037	0.474/0.029	<0.001/0.599
Phase 2 (session 7–12)	81.8 (15.2)^*	76.5 (15.2)^*	<0.001/0.902	<0.001/0.900	0.417/0.037	0.474/0.029	<0.001/0.599
Mean heart rate during training (bpm)
Phase 1 (session 1–6)	106 (10)	103 (10)	0.542/0.021		0.350/0.049		0.452/0.032
Phase 2 (session 7–12)	108 (11)	103 (11)	0.542/0.021		0.350/0.049		0.452/0.032
Mean blood pressure during training (mmHg)
Systolic
Phase 1 (session 1–6)	143.0 (9.7)	135.9 (9.7)	0.015/0.288		0.053/0.192		0.209/0.086
Phase 2 (session 7–12)	147.2 (9.7)	137.4 (9.7)	0.015/0.288		0.053/0.192		0.209/0.086
Diastolic
Phase 1 (session 1–6)	82.5 (7.8)	81.4 (7.8)	0.040/0.214		0.723/0.007		0.890/0.001
Phase 2 (session 7–12)	84.3 (7.9)	83.1 (7.9)	0.040/0.214		0.723/0.007		0.890/0.001
LOP-Left (mmHg)
Phase 1 (session 1–6)	226 (14)	228 (14)	0.072/0.169		0.246/0.074		0.100/0.143
Phase 2 (session 7–12)	217 (11)	228 (11)	0.072/0.169		0.246/0.074		0.100/0.143
LOP-Right (mmHg)
Phase 1 (session 1–6)	228 (13)	229 (13)	0.024/0.254		0.389/0.042		0.075/0.166
Phase 2 (session 7–12)	220 (14)	228 (14)	0.024/0.254		0.389/0.042		0.075/0.166

Data are provided as mean (standard deviation). BFR, BFR-training group; AC, active control group; LOP, individual limb occlusion pressure; rANOVA, repeated-measures analysis of variance. *p < 0.05, significantly different to phase 1